CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 62 filers reported holding CARDIFF ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 19.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,544 | +15.6% | 34,204 | +22.3% | 0.00% | – |
| Q2 2023 | $41,125 | +12.6% | 27,976 | +26.4% | 0.00% | – |
| Q1 2023 | $36,521 | +421.7% | 22,134 | +379.2% | 0.00% | – |
| Q3 2022 | $7,000 | -91.2% | 4,619 | -87.3% | 0.00% | – |
| Q2 2022 | $80,000 | -25.9% | 36,469 | -16.3% | 0.00% | – |
| Q1 2022 | $108,000 | -53.4% | 43,554 | +12.7% | 0.00% | – |
| Q4 2021 | $232,000 | -51.9% | 38,651 | -46.6% | 0.00% | -100.0% |
| Q3 2021 | $482,000 | +653.1% | 72,319 | +651.5% | 0.00% | – |
| Q2 2021 | $64,000 | – | 9,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,600 | $299,000 | 0.32% |
| Artal Group S.A. | 750,000 | $1,860,000 | 0.08% |
| Eventide Asset Management | 1,467,922 | $3,640,000 | 0.06% |
| Atom Investors LP | 33,798 | $84,000 | 0.04% |
| XTX Topco Ltd | 25,154 | $62,000 | 0.03% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 19,000 | $47,000 | 0.02% |
| Engineers Gate Manager LP | 245,567 | $609,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 63,749 | $158,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 168,902 | $419,000 | 0.01% |
| Walleye Capital LLC | 123,305 | $306,000 | 0.01% |